ライフサイエンスコーパス: lactulose

1 n were then measured for 3 h after 20 g oral lactulose.

2 ported with both fiber preparations and with lactulose.

3 between specimens collected before and after lactulose.

4 d may further change after administration of lactulose.

5 nd converted approximately 17% of lactose to lactulose.

6 1.9 (95 % Crl 0.2, 3.6) respectively versus lactulose.

7 xtracellular glutamate that was prevented by lactulose.

8 ts with MHE, it was not as cost-effective as lactulose.

9 She was intubated, ventilated, and placed on lactulose.

10 native beta-lactoglobulin was 69-2831 mg/L, lactulose 0-824 mg/L and furosine 3.3-68.8 mg/L.

11 8.9 +/- 4.4 and 8.9 +/- 3.9, respectively), lactulose (0.31 +/- 0.20 and 0.33 +/- 0.23, respectively

12 An oral test solution containing 5 g of lactulose, 1 g of L-rhamnose, 0.5 g of D-xylose, and 0.2

13 ) x min(-1)) is two times lower than that of lactulose (13.39 M(-1) x min(-1)).

14 harides were lactose, methyl beta-lactoside, lactulose, 4-O-beta-D-galactopyranosyl-D-mannopyranoside

15 Galbeta1,4Fru (lactulose), a natural sugar, was furthermore found to be

16 supplemented with either a placebo (10 g of lactulose, a nonabsorbable sugar), psyllium (a fermentab

17 clofenac, 0.2% glyceryl-trinitrate ointment, lactulose, a telephone number to call for queries in eme

18 Lactulose absorption (0.016-0.039 mmol.h-1.cm-1) was obs

19 ose and that the presence of glucose induced lactulose absorption and enhanced fructose absorption.

20 urve was used to calculate the purity of the lactulose (according to Van't Hoff equation), which was

21 Lactulose administration did not lead to any change in a

22 21 patients provided another specimen after lactulose administration for 55 [42-77] days.

23 healthy persons and do not change following lactulose administration.

24 h cirrhosis and assessed the effect on it of lactulose administration.

25 Despite normal mental status on lactulose after OHE, cirrhotic patients were cognitively

26 eration and absorption in the colon by using lactulose and a reduced protein diet.

27 dard treatment for hepatic encephalopathy is lactulose and alteration of gut flora.

28 arried out after intraluminal injection of H lactulose and C mannitol in the ileum of sham, B, EF, an

29 E, intravenous LOLA (as an add-on therapy to lactulose and ceftriaxone) significantly improves the gr

30 Standard of care treatment (including lactulose and ceftriaxone) was given in both groups.

31 However, lactulose and certain fructose-containing compounds, cal

32 Therapy with lactulose and enteral antibiotics is appropriate in any

33 onstituted SMPs contained high quantities of lactulose and furosine, the ratio of which was lower tha

34 ic review evaluates the effects of the NADs, lactulose and lactitol, for the treatment and prevention

35 no differences in the efficacy or safety of lactulose and lactitol.

36 s a source of several derivatives, including lactulose and lactobionic acid.

37 nd colonic transit, mucosal permeability (by lactulose and mannitol excretion), and cytokine producti

38 nd MB-301 to urinary ratios of sugar tracers lactulose and rhamnose.

39 ting events and pharmacologic treatment with lactulose and rifaximin.

40 le defect and initiation of a treatment with lactulose and the two ammonia scavenger drugs sodium ben

41 mutations in mgl are adaptations specific to lactulose and to methyl-galactoside, respectively.

42 fficed to discriminate between sugars (e.g., lactulose) and sugar alcohols (e.g., mannitol), establis

43 ides, inulin, galactooligosaccharides (GOS), lactulose, and raffinose was determined by cultural enum

44 sion of glucose into fructose and lactose to lactulose are demonstrated.

45 furosine in milk with oligosaccharides from lactulose as compared to its counterpart without this in

46 m an enzymatic process for the production of lactulose at the laboratory scale.

47 The lactulose began to decompose above 180 degrees C.

48 pe of excreted gas, a prevalence of abnormal lactulose breath test in 84% of IBS patients, and a 75%

49 After lactulose, breath hydrogen was greater on the standard t

50 n of increased rectal gas were reported with lactulose but not with either of the two fiber preparati

51 Lactose was isomerised to lactulose by microwave heating and purified by a methano

52 erein demonstrate that oligosaccharides from lactulose can be used as prebiotic ingredients in a wide

53 A final lactulose concentration of 6.7+/-0.4g/L was determined.

54 des was obtained at 70 degrees C and 60% w/w lactulose concentration, while maximum specific producti

55 -1) was obtained at 70 degrees C and 40% w/w lactulose concentration.

56 fied the whole-gut transit of a radiolabeled lactulose-containing test meal by using gamma scintigrap

57 ctulose-rich product (LRP; approximately 70% lactulose content to total sugar) through crystallizing

58 rocedure to a product with approximately 72% lactulose content.

59 Average lactulose contents from 51 to 1549 mg/L were detected at

60 using the ICT, and subsequent treatment with lactulose could substantially reduce societal costs by p

61 ntensity ultrasound (US) on the formation of lactulose during lactose isomerization and on the obtent

62 e of lactose isomerization, higher values of lactulose, epilactose and galactose being observed in co

63 vements in EED, as measured by percentage of lactulose excretion (%L). %L <0.2% was considered normal

64 Regarding the influence of US on lactulose formation, in general, in a buffered system (p

65 All patients received lactulose from 2 days before surgery for 2 weeks.

66 bstitutable resources, methylgalactoside and lactulose, generates stabilizing frequency-dependent sel

67 Lactulose had no effect on METH-induced hyperthermia.

68 on the bioactivity of oligosaccharides from lactulose has encouraged us to study their physicochemic

69 me continues, the utility and specificity of lactulose hydrogen breath testing is yet again being cal

70 me continues, the utility and specificity of lactulose hydrogen breath testing is yet again questione

71 , and it allowed quantitation of lactose and lactulose in all samples at a high level of precision an

72 n HPLC-ELSD method for the quantification of lactulose in complex sugar solutions.

73 h rifaximin was slightly more effective than lactulose in the maintenance of remission and decreased

74 Psyllium has been reported to inhibit lactulose-induced colonic mass movements and to benefit

75 ed by greater total hydrogen excretion after lactulose ingestion, a correlation between the pattern o

76 ction (measured in breath samples after oral lactulose intake).

77 Lactulose is a non-absorbable disaccharide, which alters

78 Lactulose is a well-known prebiotic and supports the all

79 ed for their ability to discriminate between lactulose, l-rhamnose, 3-O-methyl-d-glucose, and xylose.

80 Septic patients had increased lactulose/L-rhamnose urine excretion ratios (0.23 +/- 0.

81 nt with the experimental values for lactose, lactulose, lacto-N-biose, and N-acetyllactosamine, all o

82 sorbose, and tagatose and the disaccharides lactulose, maltulose, and palatinose.

83 was assessed every 6 hours by measuring the lactulose/mannitol (L/M) excretion ratio.

84 PBBV, and pBoB, LDA statistically segregated lactulose/mannitol (L/M) ratios from 0.1 to 0.5, consist

85 was assessed every 6 hours by measuring the lactulose/mannitol excretion ratio.

86 In contrast, the lactulose/mannitol ratio was only doubled in DuP753-trea

87 rs of impaired gut permeability, such as the lactulose/mannitol ratio, plasma endotoxin concentration

88 Intestinal permeability, as assessed by the lactulose/mannitol ratio, showed 6-fold and 12-fold incr

89 For 30 children, performance on the lactulose/mannitol test, a test commonly used to assess

90 We examined lactulose:mannitol (Lac:Man) permeability in obese indiv

91 egrity, which can be measured by the urinary lactulose:mannitol excretion test, deteriorates with the

92 y (based on 0-2 h levels of mannitol and the lactulose:mannitol ratio); SB permeability was greater i

93 and gut integrity [assessed by using urinary lactulose:mannitol ratios (LMRs)].

94 gars on measures of intestinal permeability (lactulose:mannitol test, plasma zonulin, and plasma lipo

95 binding modes of four galactose derivatives: lactulose, melibionic acid, thiodigalactoside, and m-nit

96 to growth-limiting concentrations of either lactulose, methyl-galactoside, or a 72:28 mixture of the

97 r, a significant increase in transepithelial lactulose movement and neutrophil migration occurred in

98 Neither the transepithelial lactulose movement in the presence of neutrophils from,

99 Ex vivo measurements of lactulose movements across intestinal epithelial monolay

100 The latter suggests that the effect of lactulose on hepatic encephalopathy may not be related t

101 Treatments considered were lactulose or rifaximin, which were assumed to reduce the

102 Although a significant change in lactulose permeability from day 1 to day 2 postinjury co

103 not be demonstrated in the B and EF groups, lactulose permeability in the B+EF group on day 2 postin

104 Lactulose permeability was increased in the injured rat

105 injury group (B+EF) had the highest level of lactulose permeability.

106 Predictors of response to lactulose, probiotics and L-ornithine-L-aspartate therap

107 Predictors of response to lactulose, probiotics, and L-ornithine-L-aspartate thera

108 Lactulose, probiotics, L-ornithine-L-aspartate, and pota

109 llowing parameters were determined (e.g. for lactulose): recovery (106+/-7%), precision (98%), correc

110 The enzymatic generation of lactulose requires fructose as nucleophilic acceptor.

111 At 90 minutes, a plasma lactulose/rhamnose concentration was also measured, with

112 s. 8.04% +/- 2.55%; p < 0.001) and increased lactulose/rhamnose ratio (2.77 +/- 4.24 vs.1.10 +/- 0.98

113 ility, as assessed by changes in the urinary lactulose/rhamnose ratio (L/R ratio) measured by High Pr

114 The lactulose/rhamnose ratio was greater in feed-intolerant

115 amnose concentration was also measured, with lactulose/rhamnose ratio, a marker of small intestinal m

116 degrees C, and gut permeability (5-h urinary lactulose:rhamnose ratios) increased 3-fold after exerci

117 ized permeate was subsequently purified to a lactulose-rich product (LRP; approximately 70% lactulose

118 Afterwards, lactose and the lactulose-rich product (PLu) were conjugated with either

119 to mannitol (L:M) and of urinary sucrose to lactulose (S:L) excretion.

120 The lactulose showed crystalline behaviour that was differen

121 th that after the nonabsorbable disaccharide lactulose suggested that the tea extract induced malabso

122 of remission from OHE; however, compared to lactulose therapy in CHE, it is not cost-effective.

123 Predictors of response to lactulose therapy in hepatic encephalopathy have been re

124 Lactulose therapy was effective for cirrhotic patients a

125 re than 90% of patients received concomitant lactulose therapy.

126 d colonic transit after consumption of 20 mL lactulose three times daily with or without 3.5 g psylli

127 primary outcomes were the ratios of urinary lactulose to mannitol (L:M) and of urinary sucrose to la

128 most commonly used test has been the urinary lactulose to mannitol ratio (L:M), which primarily asses

129 es to Cryptosporidium and rotavirus, and the lactulose to mannitol ratio for intestinal permeability

130 The d-xylose test and lactulose-to-rhamnose ratio were used to test for possib

131 tated diffusion and paracellularly (based on lactulose transport) via glucose-activated solution drag

132 ed to excitotoxicity, the effect of METH and lactulose treatment on calpain-mediated spectrin proteol

133 oducts, and this increase was prevented with lactulose treatment.

134 Disease (MELD) score, serum sodium, albumin, lactulose use, rifaximin use, and benzodiazepine/barbitu

135 of rosiglitazone therapy and treatment with lactulose, vitamin K, fresh frozen plasma, ventilatory a

136 s of fructosyl-galacto-oligosaccharides from lactulose was performed with commercial beta-galactosida

137 Diagnosis with ICT and lactulose was the most cost-effective approach (cost/MVA

138 extracellular glutamate after METH exposure, lactulose was used to decrease plasma and brain ammonia.

139 g enriched C-sucrose, 1.1 g rhamnose, 7.5 mL lactulose) was administered into the small intestine.

140 operties of juice with oligosaccharides from lactulose were acceptable and similar to those of apple

141 All four strategies with lactulose were cost-saving compared with the status quo.

142 Acarbose and lactulose were used to examine the disaccharidase-relate

143 ) and quantification (LOQ) were achieved for lactulose with 4,7-o-PBBV (LOD 41 muM, LOQ 72 muM).

144 -WbsJ has a higher affinity for lactose than lactulose with apparent Km values of 7.81 mM and 13.26 m

145 omeric region of saccharide configuration of lactulose with WPH.